A comparative analysis of HIV-specific mucosal/systemic T cell immunity and avidity following rDNA/rFPV and poxvirus-poxvirus prime boost immunisations.

Ranasinghe, Charani; Eyers, Fiona; Stambas, John; Boyle, David B; Ramshaw, Ian A; Ramsay, Alistair J

Ranasinghe, Charani; Eyers, Fiona; Stambas, John; Boyle, David B; Ramshaw, Ian A; Ramsay, Alistair J.

Affiliation

Ranasinghe C; The John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia. Charani.Ranasinghe@anu.edu.au

Vaccine ; 29(16): 3008-20, 2011 Apr 05.

Article in En | MEDLINE | ID: mdl-21352941

Subject(s)

AIDS Vaccines/immunology; CD8-Positive T-Lymphocytes/immunology; Fowlpox virus/immunology; HIV Infections/prevention & control; Immunity, Mucosal; Administration, Intranasal; Animals; Female; HIV Antibodies/blood; HIV Core Protein p24/immunology; Immunity, Cellular; Immunity, Humoral; Immunization, Secondary; Injections, Intramuscular; Interferon-gamma/immunology; Interleukin-2/immunology; Mice; Mice, Inbred BALB C; Plasmids/immunology; Vaccines, DNA/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / AIDS Vaccines / CD8-Positive T-Lymphocytes / Immunity, Mucosal / Fowlpox virus Limits: Animals Language: En Journal: Vaccine Year: 2011 Type: Article Affiliation country: Australia

Fulltext

XML

PubMed Links

Search on Google